Internal Reference Number: FOI_8598
Date Request Received: 17/04/2025 00:00:00
Date Request Replied To: 07/05/2025 00:00:00
This response was sent via: By Email
Request Summary: Multiple Myeloma
Request Category: Researcher
| Question Number 1: I have a freedom of information request regarding the treatment of Multiple Myeloma. Could you please answer the following questions. Over the past 6 months, how many adult multiple myeloma [MM] patients have you treated? If you refer your multiple myeloma patients to another centre, please state which. | |
| Answer To Question 1: Please see attached excel To accompany this answer to question 1 please also see the documents listed below:  FOI_8598 - Multiple Myeloma.xlsx | |
| Question Number 2: Of the multiple myeloma patients treated over the past 6 months, how many were treated with the following: • Any other systemic anti-cancer therapy • Belantamab Mafodotin [Blenrep] • Belantamab Mafodotin [Blenrep] with bortezomib and dexamethasone • Belantamab Mafodotin [Blenrep] with pomalidomide and dexamethasone • Bortezomib [Velcade] monotherapy or with dexamethasone • Bortezomib [Velcade], Melphalan/Cyclophosphamide and prednisolone/dexamethasone (VMp or VCd) • Bortezomib, thalidomide and dexamethasone [VTD] • Carfilzomib [Kyprolis] and dexamethasone • Carfilzomib [Kyprolis], Lenalidomide [Revlmid] and dexamethasone • Daratamumab [Darzalex] with Lenalidomide [Revlimid] and dexamethasone • Daratumumab [Darzalex] monotherapy • Daratumumab [Darzalex], Bortezomib [Velcade] and dexamethasone (known as DVd or DBd) • Daratumumab [Darzalex], Bortezomib [Velcade], thalidomide and dexamethasone (known as Dara-VTd) • Elranatamab • Idecabtagene vicleucel [Abecma] • Isatuximab [Sarclisa], Pomalidomide [Imnovid] and dexamethasone (known as IsaPd) • Ixazomib [Ninlaro], Lenalidomide [Revlmid] and dexamethasone (known as IRd) • Lenalidomide [Revlimid] and dexamethasone • Lenalidomide [Revlmid] monotherapy • Panobinostat in combination with Bortezomib and Dezamethasone • Pomalidomide [Imnovid] and dexamethasone • Selinexor and dexamethasone • Selinexor, Bortexomiv [Velcade] and dexamethasone • Talquetamab • Teclistamab [Tecvayli] | |
| Answer To Question 2: Please see attached excel | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
